http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
-
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
-
OmniAb to Participate in Five Investor Conferences in May
-
OmniAb to Report First Quarter 2024 Financial Results on May 9
-
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
-
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
-
OmniAb to Participate in Two Investor Conferences in March
-
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
-
OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event
-
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
-
OmniAb to Participate in Two Investor Conferences in November
-
OmniAb Appoints Steve Love to its Board of Directors
-
OmniAb Announces Agenda for its Research & Technology Virtual Event
-
OmniAb to Hold Research & Technology Virtual Event on November 9
-
OmniAb to Participate in Two Investor Conferences in September
-
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
-
OmniAb Announces the Passing of Director Sunil Patel
-
OmniAb to Report Second Quarter 2023 Financial Results on August 10
-
OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo
-
OmniAb Reports First Quarter 2023 Financial Results and Business Highlights
-
OmniAb to Report First Quarter 2023 Financial Results on May 11
-
OmniAb to Participate in Upcoming Investor Conferences in May
-
OmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
-
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
-
OmniAb to Participate in Three Upcoming Investor Conferences
-
OmniAb Reports Third Quarter 2022 Financial Results and Business Highlights
-
OmniAb to Participate in Two Upcoming Investor Conferences
-
OmniAb, Inc. to Ring Nasdaq Stock Market Opening Bell
-
Ligand Announces Completion of OmniAb Spin-Off
-
OmniAb Announces Completion of Spin-Off and Business Combination

